Liver Cancer Diagnostic Market Size, Share, Growth, Trends, and Global Industry Analysis: By Screening Type Outlook (Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy, Others (barium enema)), By Disease Type (Primary, Secondary, Benign Tumor Growth), By Technology (Molecular Testing, Non-Molecular Testing, Others), By Distribution Type (Hospital Associated Diagnostic Center, Independent Diagnostic Center) and Region   

Liver Cancer Diagnostic Market size was valued at US$ 9.4 bn in 2023, It is growing at a CAGR of 7.8% from 2024-2030. Liver cancer diagnostics are the techniques used for the identification and confirmation of liver cancer. Sonography, ultrasound, magnetic resonance imaging, endoscopy and bioscopy are some of the effective diagnostic techniques used in diagnosis of liver cancer. Early stage of liver cancer shows no symptom, symptoms usually appear in late stage that leading to increase patient volume available for liver cancer diagnosis and treatment. There are many screening and diagnostic tests are available for liver cancer diagnosis like lab test, imaging which helps to detect liver cancer at an early stage it carries side effects like less precision, excessive radiation exposure, and administration of florescent substances like barium for imaging and endoscopic procedures that are leading to less compliance.

In addition, the cost of diagnosis is relatively higher, hence deaths caused by liver cancer ultimately pass the burden to hospitals and medical research organizations therefore medical organizations and global pharmaceutical leaders are making efforts towards the development of newer techniques of diagnosis of liver cancer. Exposure to environmental chemicals like vinyl chloride, and benzene, and lifestyle changes expose people to the risk of liver cancer. According to the U.S. National Cancer Institute, 35,660 new cases of HCC were diagnosed and 24,550 HCC deaths occurred in the U.S. in 2015. This shows the increasing demand for diagnostic and screening techniques. Big companies like Roche Diagnostic and Abbot give their cancer test products on a license basis to regional and geographical partners that either distribute their products or manufacture reagent kits for their instruments and therefore this market holds immense potential for Liver Cancer Diagnostic Market growth.